請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/48577
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 吳信志 | |
dc.contributor.author | Shiu-Chung Wong | en |
dc.contributor.author | 王兆中 | zh_TW |
dc.date.accessioned | 2021-06-15T07:02:56Z | - |
dc.date.available | 2016-01-17 | |
dc.date.copyright | 2011-01-17 | |
dc.date.issued | 2011 | |
dc.date.submitted | 2011-01-12 | |
dc.identifier.citation | 張天鈞。2007。內科學(下冊)。橘井文化。台北市。
楊卿堯、田郁文。2007。胰島細胞移植。台灣醫學期刊。11(1),42~46。 蕭士翔。2009。綠色螢光小鼠與豬骨髓間葉幹細胞之建立與細胞治療研究,國立 臺灣大學動物科學技術學研究所博士論文。 Abdel Aziz, M. T., H. M. Atta, S. Mahfouz, H. H. Fouad, N. K. Roshdy, H. H. Ahmed, L. A. Rashed, D. Sabry, A. A. Hassouna, and N. M. Hasan. 2007. Therapeutic potential of bone marrow-derived mesenchymal stem cells on experimental liver fibrosis. Clin Biochem 40: 893-899. Ando, W., K. Tateishi, D. A. Hart, D. Katakai, Y. Tanaka, K. Nakata, J. Hashimoto, H. Fujie, K. Shino, H. Yoshikawa, and N. Nakamura. 2007. Cartilage repair using an in vitro generated scaffold-free tissue-engineered construct derived from porcine synovial mesenchymal stem cells. Biomaterials 28: 5462-5470. Ashjian, P. H., A. S. Elbarbary, B. Edmonds, D. DeUgarte, M. Zhu, P. A. Zuk, H. P. Lorenz, P. Benhaim, and M. H. Hedrick. 2003. In vitro differentiation of human processed lipoaspirate cells into early neural progenitors. Plast Reconstr Surg 111: 1922-1931. Baeyens, L., S. De Breuck, J. Lardon, J. K. Mfopou, I. Rooman, and L. Bouwens. 2005. In vitro generation of insulin-producing beta cells from adult exocrine pancreatic cells. Diab tologia 48: 49-57. Banas, A., T. Teratani, Y. Yamamoto, M. Tokuhara, F. Takeshita, G. Quinn, H. Okochi, and T. Ochiya. 2007. Adipose tissue-derived mesenchymal stem cells as a source of human hepatocytes. Hepatology 46: 219-228. Berne, R. M. 2004. Physiology. Mosby, St. Louis. Bjorntorp, P., M. Karlsson, H. Pertoft, P. Pettersson, L. Sjostrom, and U. Smith. 1978. Isolation and characterization of cells from rat adipose tissue developing into adipocytes. J Lipid Res 19: 316-324. Boluyt, M. O., G. M. Cirrincione, A. M. Loyd, D. H. Korzick, J. L. Parker, and M. H. Laughlin. 2007. Effects of gradual coronary artery occlusion and exercise training on gene expression in swine heart. Mol Cell Biochem 294: 87-96. Boumaza, I., S. Srinivasan, W. T. Witt, C. Feghali-Bostwick, Y. Dai, A. Garcia-Ocana, and M. Feili-Hariri. 2009. Autologous bone marrow-derived rat mesenchymal stem cells promote pdx-1 and insulin expression in the islets, alter t cell cytokine pattern and preserve regulatory t cells in the periphery and induce sustained normoglycemia. J Autoimmun 32: 33-42. Brambilla, G., and A. Cantafora. 2004. Metabolic and cardiovascular disorders in highly inbred lines for intensive pig farming: How animal welfare evaluation could improve the basic knowledge of human obesity. Annali dell'Istituto Superiore di Sanita 40: 241-244. Brun, T., K. H. He, R. Lupi, B. Boehm, A. Wojtusciszyn, N. Sauter, M. Donath, P. Marchetti, K. Maedler, and B. R. Gauthier. 2008. The diabetes-linked transcription factor pax4 is expressed in human pancreatic islets and is activated by mitogens and glp-1. Hum Mol Genet 17: 478-489. Butler, A. E., J. Janson, S. Bonner-Weir, R. Ritzel, R. A. Rizza, and P. C. Butler. 2003. Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes 52: 102-110. Campioni, D., R. Rizzo, M. Stignani, L. Melchiorri, L. Ferrari, S. Moretti, A. Russo, G. P. Bagnara, L. Bonsi, F. Alviano, G. Lanzoni, A. Cuneo, O. R. Baricordi, and F. Lanza. 2009. A decreased positivity for CD90 on human mesenchymal stromal cells (MSCs) is associated with a loss of immunosuppressive activity by MSCs. Cytometry B Clin Cytom 76: 225-230. Chamberlain, G., J. Fox, B. Ashton, and J. Middleton. 2007. Concise review: Mesenchymal stem cells: Their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells 25: 2739-2749. Chandra, V., S. G, S. Phadnis, P. D. Nair, and R. R. Bhonde. 2009. Generation of pancreatic hormone-expressing islet-like cell aggregates from murine adipose tissue-derived stem cells. Stem Cells 27: 1941-1953. Chang, C. H., T. F. Kuo, C. C. Lin, C. H. Chou, K. H. Chen, F. H. Lin, and H. C. Liu. 2006. Tissue engineering-based cartilage repair with allogenous chondrocytes and gelatin-chondroitin-hyaluronan tri-copolymer scaffold: A porcine model assessed at 18, 24, and 36 weeks. Biomaterials 27: 1876-1888. Chen, W. H., H. Y. Liu, W. C. Lo, S. C. Wu, C. H. Chi, H. Y. Chang, S. H. Hsiao, C. H. Wu, W. T. Chiu, B. J. Chen, and W. P. Deng. 2009. Intervertebral disc regeneration in an ex vivo culture system using mesenchymal stem cells and platelet-rich plasma. Biomaterials 30: 5523-5533. Chien, K. R. 2008. Regenerative medicine and human models of human disease. Nature 453: 302-305. D'Amour, K. A., A. D. Agulnick, S. Eliazer, O. G. Kelly, E. Kroon, and E. E. Baetge. 2005. Efficient differentiation of human embryonic stem cells to definitive endoderm. Nat Biotechnol 23: 1534-1541. da Silva Meirelles, L., P. C. Chagastelles, and N. B. Nardi. 2006. Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci 119: 2204-2213. Davani, B., L. Ikonomou, B. M. Raaka, E. Geras-Raaka, R. A. Morton, B. Marcus-Samuels, and M. C. Gershengorn. 2007. Human islet-derived precursor cells are mesenchymal stromal cells that differentiate and mature to hormone-expressing cells in vivo. Stem Cells 25: 3215-3222. De Bari, C., F. Dell'Accio, P. Tylzanowski, and F. P. Luyten. 2001. Multipotent mesenchymal stem cells from adult human synovial membrane. Arthritis Rheum 44: 1928-1942. De Ugarte, D. A., K. Morizono, A. Elbarbary, Z. Alfonso, P. A. Zuk, M. Zhu, J. L. Dragoo, P. Ashjian, B. Thomas, P. Benhaim, I. Chen, J. Fraser, and M. H. Hedrick. 2003. Comparison of multi-lineage cells from human adipose tissue and bone marrow. Cells Tissues Organs 174: 101-109. Demeterco, C., G. M. Beattie, S. A. Dib, A. D. Lopez, and A. Hayek. 2000. A role for activin a and betacellulin in human fetal pancreatic cell differentiation and growth. J Clin Endocrinol Metab 85: 3892-3897. Erices, A., P. Conget, and J. J. Minguell. 2000. Mesenchymal progenitor cells in human umbilical cord blood. Br J Haematol 109: 235-242. Friedenstein, A. J., R. K. Chailakhjan, and K. S. Lalykina. 1970. The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell and Tissue Kinetics 3: 393-403. Fujikawa, T., S. H. Oh, L. Pi, H. M. Hatch, T. Shupe, and B. E. Petersen. 2005. Teratoma formation leads to failure of treatment for type i diabetes using embryonic stem cell-derived insulin-producing cells. Am J Pathol 166: 1781-1791. Gimble, J. M., S. Zvonic, Z. E. Floyd, M. Kassem, and M. E. Nuttall. 2006. Playing with bone and fat. J Cell Biochem 98: 251-266. Gronthos, S., M. Mankani, J. Brahim, P. G. Robey, and S. Shi. 2000. Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo. Proc Natl Acad Sci 97: 13625-13630. Guilak, F., K. E. Lott, H. A. Awad, Q. Cao, K. C. Hicok, B. Fermor, and J. M. Gimble. 2006. Clonal analysis of the differentiation potential of human adipose-derived adult stem cells. J Cell Physiol 206: 229-237. Hao, E., B. Tyrberg, P. Itkin-Ansari, J. R. Lakey, I. Geron, E. Z. Monosov, M. Barcova, M. Mercola, and F. Levine. 2006. Beta-cell differentiation from nonendocrine epithelial cells of the adult human pancreas. Nat Med 12: 310-316. Hauner, H., and E. F. Pfeiffer. 1989. Regional differences in glucocorticoid action on rat adipose tissue metabolism. Horm Metab Res 21: 581-582. Hess, D., L. Li, M. Martin, S. Sakano, D. Hill, B. Strutt, S. Thyssen, D. A. Gray, and M. Bhatia. 2003. Bone marrow-derived stem cells initiate pancreatic regeneration. Nat Biotechnol 21: 763-770. Horwitz, E. M., K. Le Blanc, M. Dominici, I. Mueller, I. Slaper-Cortenbach, F. C. Marini, R. J. Deans, D. S. Krause, and A. Keating. 2005. Clarification of the nomenclature for msc: The international society for cellular therapy position statement. Cytotherapy 7: 393-395. Hu, Y., L. Liao, Q. Wang, L. Ma, G. Ma, X. Jiang, and R. C. Zhao. 2003. Isolation and identification of mesenchymal stem cells from human fetal pancreas. J Lab Clin Med 141: 342-349. Huang, J. I., S. R. Beanes, M. Zhu, H. P. Lorenz, M. H. Hedrick, and P. Benhaim. 2002. Rat extramedullary adipose tissue as a source of osteochondrogenic progenitor cells. Plast Reconstr Surg 109: 1033-1041; discussion 1042-1033. Huttenlocher, A., M. Lakonishok, M. Kinder, S. Wu, T. Truong, K. A. Knudsen, and A. F. Horwitz. 1998. Integrin and cadherin synergy regulates contact inhibition of migration and motile activity. J Cell Biol 141: 515-526. Ianus, A., G. G. Holz, N. D. Theise, and M. A. Hussain. 2003. In vivo derivation of glucose-competent pancreatic endocrine cells from bone marrow without evidence of cell fusion. J Clin Invest 111: 843-850. Ichii, H., X. Wang, S. Messinger, A. Alvarez, C. Fraker, A. Khan, Y. Kuroda, L. Inverardi, J. A. Goss, R. Alejandro, and C. Ricordi. 2006. Improved human islet isolation using nicotinamide. Am J Transplant 6: 2060-2068. Imai, H., K. Konno, M. Nakamura, T. Shimizu, C. Kubota, K. Seki, F. Honda, S. Tomizawa, Y. Tanaka, H. Hata, and N. Saito. 2006. A new model of focal cerebral ischemia in the miniature pig. J Neurosurg 104: 123-132. In 't Anker, P. S., S. A. Scherjon, C. Kleijburg-van der Keur, W. A. Noort, F. H. Claas, R. Willemze, W. E. Fibbe, and H. H. Kanhai. 2003. Amniotic fluid as a novel source of mesenchymal stem cells for therapeutic transplantation. Blood 102: 1548-1549. Kabelitz, D., E. K. Geissler, B. Soria, I. S. Schroeder, F. Fandrich, and L. Chatenoud. 2008. Toward cell-based therapy of type i diabetes. Trends Immunol 29: 68-74. Kadiyala, S., R. G. Young, M. A. Thiede, and S. P. Bruder. 1997. Culture expanded canine mesenchymal stem cells possess osteochondrogenic potential in vivo and in vitro. Cell Transplant 6: 125-134. Kasper, D. L., and T. R. Harrison. 2005. Harrison's principles of internal medicine. 16th ed. McGraw-Hill, Medical Pub. Division, New York. Kern, S., H. Eichler, J. Stoeve, H. Kluter, and K. Bieback. 2006. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells 24: 1294-1301. Kojima, H., M. Fujimiya, K. Matsumura, T. Nakahara, M. Hara, and L. Chan. 2004. Extrapancreatic insulin-producing cells in multiple organs in diabetes. Proc Natl Acad Sci 101: 2458-2463. Kotton, D., B. Ma, W. Cardoso, E. Sanderson, R. Summer, M. Williams, and A. Fine. 2001. Bone marrow-derived cells as progenitors of lung alveolar epithelium. Development 128: 5181. Kroon, E., L. A. Martinson, K. Kadoya, A. G. Bang, O. G. Kelly, S. Eliazer, H. Young, M. Richardson, N. G. Smart, J. Cunningham, A. D. Agulnick, K. A. D'Amour, M. K. Carpenter, and E. E. Baetge. 2008. Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo. Nat Biotechnol 26: 443-452. Lanza, R., and N. Rosenthal. 2004. The stem cell challenge. Sci Am 290: 92-99. Lechner, A., Y. G. Yang, R. A. Blacken, L. Wang, A. L. Nolan, and J. F. Habener. 2004. No evidence for significant transdifferentiation of bone marrow into pancreatic beta-cells in vivo. Diabetes 53: 616-623. Lee, K. D., T. K. Kuo, J. Whang-Peng, Y. F. Chung, C. T. Lin, S. H. Chou, J. R. Chen, Y. P. Chen, and O. K. Lee. 2004. In vitro hepatic differentiation of human mesenchymal stem cells. Hepatology 40: 1275-1284. Liang, C. C., A. Y. Park, and J. L. Guan. 2007. In vitro scratch assay: A convenient and inexpensive method for analysis of cell migration in vitro. Nat Protoc 2: 329-333. Liu, T. M., M. Martina, D. W. Hutmacher, J. H. Hui, E. H. Lee, and B. Lim. 2007. Identification of common pathways mediating differentiation of bone marrow- and adipose tissue-derived human mesenchymal stem cells into three mesenchymal lineages. Stem Cells 25: 750-760. Lumelsky, N., O. Blondel, P. Laeng, I. Velasco, R. Ravin, and R. McKay. 2001. Differentiation of embryonic stem cells to insulin-secreting structures similar to pancreatic islets. Science 292: 1389-1394. Lunney, J. K. 2007. Advances in swine biomedical model genomics. International Journal of Biological Sciences 3: 179-184. Marieb, E. N., and K. Hoehn. 2007. Human anatomy & physiology. Pearson Benjamin Cummings, San Francisco, Calif. Martin, D. R., N. R. Cox, T. L. Hathcock, G. P. Niemeyer, and H. J. Baker. 2002. Isolation and characterization of multipotential mesenchymal stem cells from feline bone marrow. Exp Hematol 30: 879-886. Matsui, Y., K. Zsebo, and B. L. Hogan. 1992. Derivation of pluripotential embryonic stem cells from murine primordial germ cells in culture. Cell 70: 841-847. Matz, M. V., A. F. Fradkov, Y. A. Labas, A. P. Savitsky, A. G. Zaraisky, M. L. Markelov, and S. A. Lukyanov. 1999. Fluorescent proteins from nonbioluminescent anthozoa species. Nat Biotechnol 17: 969-973. Mohan, V. 2002. Which insulin to use? Human or animal. Curr Sci 83: 1544-1547. Moscoso, I., A. Centeno, E. Lopez, J. I. Rodriguez-Barbosa, I. Santamarina, P. Filgueira, M. J. Sanchez, R. Dominguez-Perles, G. Penuelas-Rivas, and N. Domenech. 2005. Differentiation 'In vitro' Of primary and immortalized porcine mesenchymal stem cells into cardiomyocytes for cell transplantation. Transplant Proc 37: 481-482. Movassat, J., G. M. Beattie, A. D. Lopez, and A. Hayek. 2002. Exendin 4 up-regulates expression of pdx 1 and hastens differentiation and maturation of human fetal pancreatic cells. J Clin Endocrinol Metab 87: 4775-4781. Murtaugh, L. C. 2007. Pancreas and beta-cell development: From the actual to the possible. Development 134: 427-438. Naftanel, M. A., and D. M. Harlan. 2004. Pancreatic islet transplantation. PLoS Med 1: e58; quiz e75. Nauta, A. J., and W. E. Fibbe. 2007. Immunomodulatory properties of mesenchymal stromal cells. Blood 110: 3499-3506. Neupane, M., C. C. Chang, M. Kiupel, and V. Yuzbasiyan-Gurkan. 2008. Isolation and characterization of canine adipose-derived mesenchymal stem cells. Tissue Eng Part A 14: 1007-1015. Oliver-Krasinski, J. M., and D. A. Stoffers. 2008. On the origin of the beta cell. Genes & Development 22: 1998-2021. Palmer, T. D., E. A. Markakis, A. R. Willhoite, F. Safar, and F. H. Gage. 1999. Fibroblast growth factor-2 activates a latent neurogenic program in neural stem cells from diverse regions of the adult cns. J Neurosci 19: 8487-8497. Parekkadan, B., and J. M. Milwid. 2010. Mesenchymal stem cells as therapeutics. Annu Rev Biomed Eng 12: 87-117. Pereira, R. F., K. W. Halford, M. D. O'Hara, D. B. Leeper, B. P. Sokolov, M. D. Pollard, O. Bagasra, and D. J. Prockop. 1995. Cultured adherent cells from marrow can serve as long-lasting precursor cells for bone, cartilage, and lung in irradiated mice. Proc Natl Acad Sci 92: 4857-4861. Pittenger, M. F., A. M. Mackay, S. C. Beck, R. K. Jaiswal, R. Douglas, J. D. Mosca, M. A. Moorman, D. W. Simonetti, S. Craig, and D. R. Marshak. 1999. Multilineage potential of adult human mesenchymal stem cells. Science 284: 143-147. Plitzko, D., S. Rumpel, and K. Gottmann. 2001. Insulin promotes functional induction of silent synapses in differentiating rat neocortical neurons. Eur J Neurosci 14: 1412-1415. Ponte, A. L., E. Marais, N. Gallay, A. Langonne, B. Delorme, O. Herault, P. Charbord, and J. Domenech. 2007. The in vitro migration capacity of human bone marrow mesenchymal stem cells: Comparison of chemokine and growth factor chemotactic activities. Stem Cells 25: 1737-1745. Puissant, B., C. Barreau, P. Bourin, C. Clavel, J. Corre, C. Bousquet, C. Taureau, B. Cousin, M. Abbal, P. Laharrague, L. Penicaud, L. Casteilla, and A. Blancher. 2005. Immunomodulatory effect of human adipose tissue-derived adult stem cells: Comparison with bone marrow mesenchymal stem cells. Br J Haematol 129: 118-129. Qu, C. Q., G. H. Zhang, L. J. Zhang, and G. S. Yang. 2007. Osteogenic and adipogenic potential of porcine adipose mesenchymal stem cells. In Vitro Cellular & Developmental Biology Animal 43: 95-100. Ringe, J., C. Kaps, B. Schmitt, K. Buscher, J. Bartel, H. Smolian, O. Schultz, G. R. Burmester, T. Haupl, and M. Sittinger. 2002. Porcine mesenchymal stem cells. Induction of distinct mesenchymal cell lineages. Cell Tissue Res 307: 321-327. Robertson, R. P., C. Davis, J. Larsen, R. Stratta, and D. E. Sutherland. 2000. Pancreas and islet transplantation for patients with diabetes. Diabetes Care 23: 112-116. Ryan, E. A., B. W. Paty, P. A. Senior, D. Bigam, E. Alfadhli, N. M. Kneteman, J. R. Lakey, and A. M. Shapiro. 2005. Five-year follow-up after clinical islet transplantation. Diabetes 54: 2060-2069. Sabatini, F., L. Petecchia, M. Tavian, V. Jodon de Villeroche, G. A. Rossi, and D. Brouty-Boye. 2005. Human bronchial fibroblasts exhibit a mesenchymal stem cell phenotype and multilineage differentiating potentialities. Lab Invest 85: 962-971. Safford, K. M., K. C. Hicok, S. D. Safford, Y. D. Halvorsen, W. O. Wilkison, J. M. Gimble, and H. E. Rice. 2002. Neurogenic differentiation of murine and human adipose-derived stromal cells. Biochem Biophys Res Commun 294: 371-379. Salem, H. K., and C. Thiemermann. 2010. Mesenchymal stromal cells: Current understanding and clinical status. Stem Cells 28: 585-596. Sanchez-Ramos, J., S. Song, F. Cardozo-Pelaez, C. Hazzi, T. Stedeford, A. Willing, T. B. Freeman, S. Saporta, W. Janssen, N. Patel, D. R. Cooper, and P. R. Sanberg. 2000. Adult bone marrow stromal cells differentiate into neural cells in vitro. Exp Neurol 164: 247-256. Sapir, T., K. Shternhall, I. Meivar-Levy, T. Blumenfeld, H. Cohen, E. Skutelsky, S. Eventov-Friedman, I. Barshack, I. Goldberg, S. Pri-Chen, L. Ben-Dor, S. Polak-Charcon, A. Karasik, I. Shimon, E. Mor, and S. Ferber. 2005. Cell-replacement therapy for diabetes: Generating functional insulin-producing tissue from adult human liver cells. Proc Natl Acad Sci 102: 7964-7969. Schaffler, A., and C. Buchler. 2007. Concise review: Adipose tissue-derived stromal cells--basic and clinical implications for novel cell-based therapies. Stem Cells 25: 818-827. Schroeder, T. 2008. Imaging stem-cell-driven regeneration in mammals. Nature 453: 345-351. Serup, P., O. D. Madsen, and T. Mandrup-Poulsen. 2001. Islet and stem cell transplantation for treating diabetes. BMJ 322: 29-32. Shamblott, M., J. Axelman, S. Wang, E. Bugg, J. Littlefield, P. Donovan, P. Blumenthal, G. Huggins, and J. Gearhart. 1998a. Derivation of pluripotent stem cells from cultured human primordial germ cells. Proc Natl Acad Sci 95: 13726. Shamblott, M. J., J. Axelman, S. Wang, E. M. Bugg, J. W. Littlefield, P. J. Donovan, P. D. Blumenthal, G. R. Huggins, and J. D. Gearhart. 1998b. Derivation of pluripotent stem cells from cultured human primordial germ cells. Proc Natl Acad Sci 95: 13726-13731. Shapiro, A. M., J. R. Lakey, E. A. Ryan, G. S. Korbutt, E. Toth, G. L. Warnock, N. M. Kneteman, and R. V. Rajotte. 2000. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 343: 230-238. Sonoyama, W., Y. Liu, D. Fang, T. Yamaza, B. M. Seo, C. Zhang, H. Liu, S. Gronthos, C. Y. Wang, S. Wang, and S. Shi. 2006. Mesenchymal stem cell-mediated functional tooth regeneration in swine. PLoS ONE 1: e79. Soria, B., E. Roche, G. Berna, T. Leon-Quinto, J. A. Reig, and F. Martin. 2000. Insulin-secreting cells derived from embryonic stem cells normalize glycemia in streptozotocin-induced diabetic mice. Diabetes 49: 157-162. Takahashi, J., T. D. Palmer, and F. H. Gage. 1999. Retinoic acid and neurotrophins collaborate to regulate neurogenesis in adult-derived neural stem cell cultures. J Neurobiol 38: 65-81. Taneera, J., A. Rosengren, E. Renstrom, J. M. Nygren, P. Serup, P. Rorsman, and S. E. Jacobsen. 2006. Failure of transplanted bone marrow cells to adopt a pancreatic beta-cell fate. Diabetes 55: 290-296. Tang, D. Q., L. Z. Cao, B. R. Burkhardt, C. Q. Xia, S. A. Litherland, M. A. Atkinson, and L. J. Yang. 2004. In vivo and in vitro characterization of insulin-producing cells obtained from murine bone marrow. Diabetes 53: 1721-1732. Tang, W., D. Zeve, J. M. Suh, D. Bosnakovski, M. Kyba, R. E. Hammer, M. D. Tallquist, and J. M. Graff. 2008. White fat progenitor cells reside in the adipose vasculature. Science 322: 583-586. Tang, Y., X. Wu, W. Lei, L. Pang, C. Wan, Z. Shi, L. Zhao, T. R. Nagy, X. Peng, J. Hu, X. Feng, W. Van Hul, M. Wan, and X. Cao. 2009. Tgf-beta1-induced migration of bone mesenchymal stem cells couples bone resorption with formation. Nat Med 15: 757-765. Timper, K., D. Seboek, M. Eberhardt, P. Linscheid, M. Christ-Crain, U. Keller, B. Muller, and H. Zulewski. 2006. Human adipose tissue-derived mesenchymal stem cells differentiate into insulin, somatostatin, and glucagon expressing cells. Biochem Biophys Res Commun 341: 1135-1140. Tio, M., K. H. Tan, W. Lee, T. T. Wang, and G. Udolph. 2010. Roles of db-camp, ibmx and ra in aspects of neural differentiation of cord blood derived mesenchymal-like stem cells. PLoS ONE 5: e9398. Trommelmans, L. 2010. The challenge of regenerative medicine. Hastings Cent Rep 40: 24-26. Tropel, P., N. Platet, J. C. Platel, D. Noel, M. Albrieux, A. L. Benabid, and F. Berger. 2006. Functional neuronal differentiation of bone marrow-derived mesenchymal stem cells. Stem Cells 24: 2868-2876. Turk, J. R., K. K. Henderson, G. D. Vanvickle, J. Watkins, and M. H. Laughlin. 2005. Arterial endothelial function in a porcine model of early stage atherosclerotic vascular disease. Int J Exp Pathol 86: 335-345. Wagner, W., F. Wein, A. Seckinger, M. Frankhauser, U. Wirkner, U. Krause, J. Blake, C. Schwager, V. Eckstein, W. Ansorge, and A. D. Ho. 2005. Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood. Exp Hematol 33: 1402-1416. Wakitani, S., T. Saito, and A. I. Caplan. 1995. Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5-azacytidine. Muscle a d Nerve 18: 1417-1426. Wan, Q., Z. G. Xiong, H. Y. Man, C. A. Ackerley, J. Braunton, W. Y. Lu, L. E. Becker, J. F. MacDonald, and Y. T. Wang. 1997. Recruitment of functional gaba receptors to postsynaptic domains by insulin. Nature 388: 686-690. Wang, T. T., M. Tio, W. Lee, W. Beerheide, and G. Udolph. 2007. Neural differentiation of mesenchymal-like stem cells from cord blood is mediated by pka. Biochem Biophys Res Commun 357: 1021-1027. Watremez, C., J. Roeseler, M. De Kock, T. Clerbaux, B. Detry, C. Veriter, M. Reynaert, P. Gianello, P. Jolliet, and G. Liistro. 2003. An improved porcine model of stable methacholine-induced bronchospasm. Intensive Care Med 29: 119-125. Wild, S., G. Roglic, A. Green, R. Sicree, and H. King. 2004. Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care 27: 1047-1053. Ye, D. Z., M. H. Tai, K. D. Linning, C. Szabo, and L. K. Olson. 2006. Mafa expression and insulin promoter activity are induced by nicotinamide and related compounds in ins-1 pancreatic beta-cells. Diabetes 55: 742-750. Young, H. E., M. L. Mancini, R. P. Wright, J. C. Smith, A. C. Black, Jr., C. R. Reagan, and P. A. Lucas. 1995. Mesenchymal stem cells reside within the connective tissues of many organs. Dev Dyn 202: 137-144. Zhang, D., W. Jiang, M. Liu, X. Sui, X. Yin, S. Chen, Y. Shi, and H. Deng. 2009. Highly efficient differentiation of human es cells and ips cells into mature pancreatic insulin-producing cells. Cell Res 19: 429-438. Zhang, Y. Q., M. M. Cleary, Y. Si, G. Liu, Y. Eto, M. Kritzik, S. Dabernat, A. G. Kayali, and N. Sarvetnick. 2004. Inhibition of activin signaling induces pancreatic epithelial cell expansion and diminishes terminal differentiation of pancreatic beta-cells. Diabetes 53: 2024-2033. Zuk, P. A. 2010. The adipose-derived stem cell: Looking back and looking ahead. Mol Biol Cell 21: 1783-1787. Zuk, P. A., M. Zhu, P. Ashjian, D. A. De Ugarte, J. I. Huang, H. Mizuno, Z. C. Alfonso, J. K. Fraser, P. Benhaim, and M. H. Hedrick. 2002. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 13: 4279-4295. Zuk, P. A., M. Zhu, H. Mizuno, J. Huang, J. W. Futrell, A. J. Katz, P. Benhaim, H. P. Lorenz, and M. H. Hedrick. 2001. Multilineage cells from human adipose tissue: Implications for cell-based therapies. Tissue Eng 7: 211-228. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/48577 | - |
dc.description.abstract | 成體幹細胞為生物體內能夠自我更新並分化成其他成熟體細胞且進行組織及器官之修復。近年來發現間葉幹細胞(mesenchymal stem cells)可分離自哺乳動物體內許多組織中,例如骨髓、脂肪、關節滑液、臍帶、肌肉及胎盤等,雖然來自不同組織中之間葉幹細胞有許多相似特性,但也因為來源不同,在各種分化及生長特性亦有所差異。由於具多分化潛能且道德爭議較胚胎來源幹細胞小等優點,間葉幹細胞在未來細胞治療之再生醫學領域有著極大的潛力。但在應用於臨床試驗前尚有許多未知的挑戰尚待解決,因此需要有良好的研究工具來釐清問題,以增加人們對幹細胞基本知識之了解,另外可針對特定之人類疾病或組織損傷,透過動物模式之幹細胞治療研究結果,探討移植入的細胞對該疾病是否有改善的功效。
本研究分離同一紅螢光蛋白質(red fluorescent protein, RFP)基因轉殖豬之骨髓間葉幹細胞及脂肪幹細胞,此基因轉殖豬全身皆表現 RFP,RFP 基因為一廣泛運用之報導基因,可應用於細胞治療後之追蹤試驗。本研究之目的係分離同一紅螢光豬之骨髓間葉幹細胞(RFP porcine bone marrow mesenchymal stem cells, rpBMMSCs)及脂肪幹細胞(RFP porcine adipose tissue-derived stem cells, rpADSCs),並比較二種來源之幹細胞之增殖特性、免疫表現型、遷移能力、免疫調節作用及分化潛能,且進行其分化前及後之特性分析,做為未來幹細胞活體移植試驗之參考。 針對 rpADSCs 及 rpBMMSCs 增殖試驗之比較結果顯示,rpADSCs在連續繼代至 passage 6(p6)時,細胞倍增時間明顯高於 p3(p < 0.01) ,但 rpBMMSCs 則無此現象出現。在產生成纖維母細胞聚落之能力測定上, rpADSCs 明顯的具有較 rpBMMSCs 為高之細胞聚落形成能力(p < 0.05) 。此外,藉由流式細胞儀分析結果,證明其兩種細胞皆表現間葉幹細胞之表面抗原包括 CD29、CD44、CD90;惟不表現造血幹細胞之表面抗原諸如 CD4a、CD31、CD45 。以混合淋巴球反應(mix lymphocyte reaction, MLR)及裂殖原增生反應(mitogen proliferation assay, MPA)探討 rpBMMSCs 及 rpADSCs 之免疫調節特性,結果顯示兩種細胞皆能有效地降低淋巴球之增生(p < 0.01) 。此外,在細胞傷口癒合能力分析中,rpADSCs 在遷移能力上較 rpBMMSCs 迅速。分化潛能方面 rpBMMSCs 及 rpADSCs 皆能分化為中胚層之硬骨及脂肪細胞,其中 rpBMMSCs 在分化為硬骨效率明顯較高,而脂肪分化的效率則以 rpADSCs 較高。從 RT-PCR 結果亦可顯現其相關脂肪分化基因 FABP4 (fatty acid binding protein 4)及硬骨分化基因 osteonectin 及 osteocalcin 表達。 除了針對 rpBMMSCs 及 rpADSCs 進行基本間葉幹細胞特性之分析外,本試驗進一步規劃進行rpADSCs 跨胚層之分化試驗,將 rpADSCs 以神經分化培養液處理後證實可表現相關神經前軀細胞之基因,且透過細胞免疫染色可觀察到專一表現於神經前軀細胞之 βIII-tubulin,證明其具有分化成特定外胚層來源細胞之能力,且持續表現紅螢光蛋白質。至於分化為內胚層來源細胞能力,則可將 rpADSCs 預培養為立體結構之細胞團塊下,以高葡萄糖濃度之分化培養液培養十天後,可觀察其表現特定胰島細胞之基因,往後應更近一步確認其是否具有分泌胰島素且具有調節血糖之功能,若未來改善分化條件以引導細胞能更往成熟之胰島細胞分化,將來 ADSCs 可作為分泌胰島素功能之細胞取代胰島移植之細胞來源,以解決胰島素依賴型糖尿病之問題 。 綜合上述結果顯示,本試驗分離之 rpBMMSCs 及 rpADSCs 殊能符合多項間葉幹細胞所具有之特性且 RFP 基因於分化前後之表現穩定,雖然兩種不同來源之間葉幹細胞在各種特性上有所差異,惟此差異也可供未來不同細胞治療之幹細胞來源參考,此兩種細胞可望在未來應用於幹細胞治療之動物模式研究。 | zh_TW |
dc.description.abstract | Adult stem cells are undifferentiated cells found in living organisms that can selfrenew and can differentiate to yield major specialized cell types of the tissue or organ. Mesenchymal stem cells (MSCs) are adult stem cells found in various tissues, such as bone marrow, adipose tissue, umbilical cord, synovium, skeletal muscle and placenta. Although MSCs isolated from different sites have similar phenotype, they may exhibit heterogeneity in differentiation potentials, which related to the tissue sources. Several characteristics, such as multipotency and less ethical concerned make MSCs hold the promise to restore human damaged tissue or organs, but it also faces tremendous challenges on the way to reach clinical application. To elucidate all these problems, improvement of research tools should be applied to gain knowledge from basic cell culture system and model organism.
To understand which tissue derivative stem cells will be proper graft materials for repairing target tissue in the future. MSCs were isolated from bone marrow and adipose tissue of transgenic pigs expressing red fluorescent proteins (RFP) gene, an ideal tracing marker used to monitor cellular processes in living systems. Herein, we aim to isolate two kinds of adult stem cells, RFP porcine bone marrow mesenchymal stem cells (rpBMMSCs) and RFP porcine adipose tissue-derived stem cells (rpADSCs) from the same RFP transgenic pigs, and verify their characterizations of proliferation, differentiation, migration, immunosupression properties and expression of surface markers. In proliferation capacity, rpADSCs showed higher colony forming unit fibroblasts (CFU-Fs) than rpBMMSCs (p < 0.05), but rpBMMSCs exhibited the same population doubling time in serial passage to p6. In contrast, proliferation ability of rpADSCs decreased in p6 (p < 0.01). The result in surface markers assay indicated that both rpBMMSCs and rpADSCs are positive in CD29, CD44 and CD90 mesenchymal stem cell surface markers and negative in CD31, CD45 and CD4a hematopoietic cell markers. In mitogen proliferation assay and mix lymphocyte reaction, peripheral blood mononuclear cell proliferation was eased by these two cell types (p < 0.01), which validated the immunomodulatory feature of mesenchymal stem cells. Wound healing assay revealed that rpADSCs migrated faster than rpBMMSCs. Differentiation potency were investigated by osteogenic and adipogenic differentiation. Extracellular calcium produced by rpBMMSCs was higher in osteogenic induction, whereas oil accumulation of induced rpADSCs was higher in adipogenic culture. Adiogenic related gene, adipocyte fatty acid binding protein (FABP4) and osteogenic related gene, osteonectin and osteocalsin gene expressions were also confirmed by RT-PCR. All of differentiated cells expressed RFP gene stably. These results might represent that characteristics of stem cells are tend to fit their original niche. Except characterizing the properties of mesenchymal stem cells for these two cell types, we also proceeded trans-differentiation experiments for rpADSCs. After neural induction medium treatment for three days, rpADSCs expressed several genes related to neural progenitor cell and neural specific βIII-tubulin could be observed in some cells. On the other hand, pancreatic islet differentiation of rpADSCs was induced by high glucose induction medium and three-dimensional culture. Several pancreatic genes, such as Ngn3, NeuroD and Nkx6.1, were detected by RT-PCR in differentiated cells. The next step is to check the function of these cells comparing with mature islet to demonstrate wether ADSCs is a good candidate cell type for islet transplantation. Taken together, both rpBMMSCs and rpADSCs possess regular mesenchymal stem cell properties that can be applied to cell tracing in model animal and some different characteristics of them may influence their future application in regenerative medicine. | en |
dc.description.provenance | Made available in DSpace on 2021-06-15T07:02:56Z (GMT). No. of bitstreams: 1 ntu-100-R97626016-1.pdf: 18442427 bytes, checksum: 8b096e28845171e2ca8a5891f716e223 (MD5) Previous issue date: 2011 | en |
dc.description.tableofcontents | 謝誌...................................................................................... I
目錄...................................................................................... II 圖次 ...................................................................................... V 表次 ...................................................................................... VII 附表次................................................................................... VII 中文摘要................................................................................ XIII 英文摘要 ............................................................................... X 第壹章、前言.......................................................................... 1 第貳章、文獻檢討................................................................... 2 2.1 幹細胞(Stem cells)................................................... 2 2.1.1 幹細胞簡介............................................................ 2 2.1.2 間葉幹細胞............................................................ 2 2.1.3 脂肪幹細胞............................................................ 5 2.2 豬之模式動物運用於幹細胞研究現況................................ 7 2.2.1 豬作為模式動物簡介................................................ 7 2.2.2 豬模式動物於幹細胞研究之應用................................ 7 2.3 胰臟與內分泌調控......................................................... 10 2.3.1 胰臟的組成............................................................ 10 2.3.2 胰臟之胚胎發育...................................................... 10 2.3.3 胰島對血糖之調控 ................................................... 13 2.3.4 胰島素的生成......................................................... 15 2.4 糖尿病......................................................................... 16 2.4.1 糖尿病簡介............................................................ 16 2.4.2 第一型糖尿病(Type I Diabetes)........................... 17 2.5 幹細胞於第一型糖尿病治療之研究現況............................ 18 2.5.1 胚胎幹細胞與第一型糖尿病..................................... 18 2.5.2 成體幹細胞與第一型糖尿病治療之研究..................... 19 第參章、試驗研究.................................................................. 21 試驗一、紅螢光豬骨髓間葉幹細胞與脂肪幹細胞之分離 及生長特性之比較.............................................................. 21 (一)前言............................................................................ 21 (二)材料與方法.................................................................. 21 (三)結果與討論................................................................. 26 試驗二、紅螢光豬脂肪幹細胞與骨髓間葉幹細胞之免疫 表現型及免疫調節特性之比較.............................................. 30 (一)前言........................................................................... 30 (二)材料與方法.................................................................. 30 (三)結果與討論.................................................................. 32 試驗三、紅螢光豬脂肪幹細胞與骨髓間葉幹細胞之遷移特 性及分化潛能分析............................................................. 38 (一)前言.......................................................................... 38 (二)材料與方法................................................................ 38 (三)結果與討論................................................................ 41 試驗四、紅螢光豬脂肪幹細胞跨胚層分化潛能分析.................... 53 (一)前言.......................................................................... 53 (二)材料與方法................................................................. 53 (三)結果與討論................................................................. 56 第肆章、結論....................................................................... 61 參考文獻............................................................................. 62 附錄 ................................................................................... 70 圖 次 圖 1. 間葉幹細胞之多分化潛能.................................................. 4 圖 2. 間葉幹細胞之免疫調節特性............................................... 5 圖 3. 脂肪幹細胞之分離方法..................................................... 6 圖 4. 胰臟之構造..................................................................... 11 圖 5. 小鼠胚胎胰臟之胰臟發育.................................................. 12 圖 6. 胰臟細胞發育之基因調控.................................................. 13 圖 7. 葡萄糖刺激胰島素分泌之機制............................................ 14 圖 8. 胰島素之生物合成............................................................ 15 圖 9. 臨床胰島細胞移植流程圖.................................................. 18 圖 10. 基因轉殖紅螢光豬載體之構築.......................................... 22 圖 11. 紅螢光豬骨髓間葉幹細胞之分離方法................................. 25 圖 12. 紅螢光豬脂肪幹細胞之分離方法....................................... 25 圖 13. 紅螢光豬骨髓間葉幹細胞................................................. 27 圖 14. 紅螢光豬骨髓間葉幹細胞及脂肪幹細胞之代數及倍增時 間關係圖............................................................................ 28 圖 15. 紅螢光豬骨髓間葉幹細胞及脂肪幹細胞聚落形成型態.......... 29 圖 16. 紅螢光豬骨髓間葉幹細胞及脂肪幹細胞陽性免疫表現型....... 34 圖 17. 紅螢光豬骨髓間葉幹細胞及脂肪幹細胞陰性免疫表現型....... 35 圖 18. 紅螢光豬骨髓間葉幹細胞與脂肪幹細胞之裂殖原增生反 應..................................................................................... 36 圖 19. 紅螢光豬骨髓間葉幹細胞與脂肪幹細胞之混合淋巴球反 應...................................................................................... 37 圖 20. 紅螢光豬骨髓間葉幹細胞及脂肪幹細胞細胞傷口癒合分 析...................................................................................... 44 圖 21. 紅螢光豬骨髓間葉幹細胞及脂肪幹細胞細胞傷口癒合分 析遷移面積計算圖................................................................. 46 圖 22. 紅螢光豬骨髓間葉幹細胞與)脂肪幹細胞脂肪分化之油 紅染色................................................................................. 47 圖 23. 紅螢光豬骨髓間葉幹細胞與脂肪幹細胞脂肪分化之油紅 染色定量圖.......................................................................... 48 圖 24. 紅螢光豬脂肪幹細胞與骨髓間葉幹細胞脂肪分化之基因 表現................................................................................... 48 圖 25. 紅螢光豬骨髓間葉幹細胞與脂肪幹細胞硬骨分化於 7、 14、21 天之 ARS 染色圖...................................................... 49 圖 26. 紅螢光豬骨髓間葉幹細胞與脂肪幹細胞硬骨分化之 ARS 染色定量圖......................................................................... 50 圖 27. 紅螢光豬骨髓間葉幹細胞與脂肪幹細胞硬骨分化之基因 表現................................................................................... 51 圖 28. 紅螢光豬骨髓間葉幹細胞與脂肪幹細胞脂肪及硬骨分化 皆表現紅色螢光蛋白............................................................. 52 圖 29. 紅螢光豬脂肪幹細胞神經分化表現神經細胞專一之 beta III tubulin 及紅色螢光基因................................................... 58 圖 30. 紅螢光豬脂肪幹細胞神經分化基因表現............................. 58 圖 31. 以團塊結構對 rpADSCs 進行胰島分化.............................. 59 圖 32. 紅螢光豬脂肪幹細胞胰島分化基因表現............................. 60 表 次 表 1. 利用豬作為生醫模式動物之優點........................................ 8 表 2. 常見生醫研究之豬動物模式............................................... 9 表 3. 紅螢光豬骨髓間葉幹細胞及脂肪幹細胞聚落形成數量............ 29 附表次 附表 1. 本試驗所使用之引子.................................................... 70 | |
dc.language.iso | zh-TW | |
dc.title | 紅螢光蛋白質基因轉殖豬之骨髓間葉幹細胞及脂肪幹細胞特性分析 | zh_TW |
dc.title | Characterization of bone marrow-derived stem cells and adipose tissue-derived stem cells isolated from transgenic pigs expressing red fluorescent protein | en |
dc.type | Thesis | |
dc.date.schoolyear | 99-1 | |
dc.description.degree | 碩士 | |
dc.contributor.coadvisor | 丁詩同 | |
dc.contributor.oralexamcommittee | 鄭登貴,陳全木 | |
dc.subject.keyword | 紅螢光基因豬,幹細胞,骨髓,脂肪組織,神經分化,胰島分化, | zh_TW |
dc.subject.keyword | RFP transgenic pigs,adult stem cells,bone marrow,adipose tissue,neural differentiation,pancreatic islet differentiation, | en |
dc.relation.page | 70 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2011-01-12 | |
dc.contributor.author-college | 生物資源暨農學院 | zh_TW |
dc.contributor.author-dept | 動物科學技術學研究所 | zh_TW |
顯示於系所單位: | 動物科學技術學系 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-100-1.pdf 目前未授權公開取用 | 18.01 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。